145 related articles for article (PubMed ID: 23923663)
1. Activated charcoal adsorption of volatile anesthetic agents for anesthesia machine preparation of malignant hyperthermia susceptible patients.
Martin JW; Welliver MD
AANA J; 2013 Jun; 81(3):169-71. PubMed ID: 23923663
[No Abstract] [Full Text] [Related]
2. Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.
Birgenheier N; Stoker R; Westenskow D; Orr J
Anesth Analg; 2011 Jun; 112(6):1363-70. PubMed ID: 21543783
[TBL] [Abstract][Full Text] [Related]
3. Malignant hyperthermia: removal of volatile anesthetic agents from the breathing circuit using activated charcoal.
Greene ER
Anesthesiology; 1986 Aug; 65(2):240-1. PubMed ID: 3740531
[No Abstract] [Full Text] [Related]
4. Efficacy of Malignant Hyperthermia Association of the United States-Recommended Methods of Preparation for Malignant Hyperthermia-Susceptible Patients Using Dräger Zeus Anesthesia Workstations and Associated Costs.
Neira VM; Al Madhoun W; Ghaffari K; Barrowman N; Berrigan P; Splinter W
Anesth Analg; 2019 Jul; 129(1):74-83. PubMed ID: 29847377
[TBL] [Abstract][Full Text] [Related]
5. Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.
Gunter JB; Ball J; Than-Win S
Anesth Analg; 2008 Dec; 107(6):1936-45. PubMed ID: 19020141
[TBL] [Abstract][Full Text] [Related]
6. Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients.
Heiderich S; Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Reitz M; Rüffert H
BMC Anesthesiol; 2021 Dec; 21(1):315. PubMed ID: 34903173
[TBL] [Abstract][Full Text] [Related]
7. Comparing charcoal and zeolite reflection filters for volatile anaesthetics: A laboratory evaluation.
Sturesson LW; Frennström JO; Ilardi M; Reinstrup P
Eur J Anaesthesiol; 2015 Aug; 32(8):521-6. PubMed ID: 25387299
[TBL] [Abstract][Full Text] [Related]
8. [An activated charcoal filter for eliminating volatile anesthetics. A contribution to the management of malignant hyperthermia].
Jantzen JP; Eck J; Kleemann PP
Anaesthesist; 1989 Nov; 38(11):639-41. PubMed ID: 2635839
[TBL] [Abstract][Full Text] [Related]
9. Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients.
Prinzhausen H; Crawford MW; O'Rourke J; Petroz GC
Can J Anaesth; 2006 Sep; 53(9):885-90. PubMed ID: 16960266
[TBL] [Abstract][Full Text] [Related]
10. Malignant hyperthermia and charcoal absorbent: too hot to handle.
Block FE
Anesth Analg; 2011 Jun; 112(6):1270-1. PubMed ID: 21613194
[No Abstract] [Full Text] [Related]
11. The use of charcoal filters in malignant hyperthermia: have they found their place?
Bilmen JG; Hopkins PM
Anaesthesia; 2019 Jan; 74(1):13-16. PubMed ID: 30088269
[No Abstract] [Full Text] [Related]
12. Ambulatory surgery and malignant hyperthermia.
Brandom BW
Curr Opin Anaesthesiol; 2009 Dec; 22(6):744-7. PubMed ID: 19812484
[TBL] [Abstract][Full Text] [Related]
13. Preparation of anaesthesia workstation for trigger-free anaesthesia: An observational laboratory study.
Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Rüffert H; Heiderich S
Eur J Anaesthesiol; 2019 Nov; 36(11):851-856. PubMed ID: 31580288
[TBL] [Abstract][Full Text] [Related]
14. Residual volatile anesthetics after workstation preparation and activated charcoal filtration.
Müller-Wirtz LM; Godsch C; Sessler DI; Volk T; Kreuer S; Hüppe T
Acta Anaesthesiol Scand; 2020 Jul; 64(6):759-765. PubMed ID: 32153012
[TBL] [Abstract][Full Text] [Related]
15. How will we ever know if our machine is adequately flushed?
Martin TW; Block FE
Anesth Analg; 2014 Jul; 119(1):9-10. PubMed ID: 24945118
[No Abstract] [Full Text] [Related]
16. Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia.
Shanahan H; O'Donoghue R; O'Kelly P; Synnott A; O'Rourke J
Eur J Anaesthesiol; 2012 May; 29(5):229-34. PubMed ID: 22388705
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia during sevoflurane anaesthesia in arthrogryposis multiplex congenita with central nervous system dysfunction.
Kanaya N; Nakayama M; Nakae Y; Kobayashi I; Tsuchida H; Namiki A
Paediatr Anaesth; 1996; 6(5):428-9. PubMed ID: 8880828
[No Abstract] [Full Text] [Related]
18. Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients.
Bilmen JG; Gillies RI
Anaesth Intensive Care; 2014 Jan; 42(1):51-8. PubMed ID: 24471664
[TBL] [Abstract][Full Text] [Related]
19. Preparation of the Dräger Fabius GS workstation for malignant hyperthermia-susceptible patients.
Whitty RJ; Wong GK; Petroz GC; Pehora C; Crawford MW
Can J Anaesth; 2009 Jul; 56(7):497-501. PubMed ID: 19399571
[TBL] [Abstract][Full Text] [Related]
20. A case of malignant hyperthermia captured by an anesthesia information management system.
Maile MD; Patel RA; Blum JM; Tremper KK
J Clin Monit Comput; 2011 Apr; 25(2):109-11. PubMed ID: 21638068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
